BioSpace News Archive

The peptide therapeutics market was valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027; it is expected to grow at a CAGR of 9.2% from 2020 to 2027.

The sports medicine devices market accounted to US$ 5,822.6 Mn in 2017 and is expected to grow at a CAGR of 7.9% during the forecast period 2018 - 2025, to account to US$ 10,662.5 Mn by 2025.

For the first half of 2021, Median Technologies’ revenue amounts to €10.1m, up 71% compared to the H1 2020 revenue, which stood at €5.9m.

Pharmaceutical Executive®, a leading multimedia platform for industry leaders to exchange experiences and insights about innovative business and marketing ideas, is pleased to officially announce the finalists for the first annual Pharmaceutical Executive® 2021 APEX Awards.

Breaking research published in AACC’s The Journal of Applied Laboratory Medicine has found that, at the start of the pandemic, the two demographic groups most likely to get COVID-19 were low socioeconomic status Black people and high socioeconomic status White people.

Artificial Intelligence (AI) is the potential of the computer-controlled robot or computer to carry out tasks that are usually associated with intelligent beings.

Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, announced that Carole Ben-Maimon, MD, President and Chief Executive Officer of Larimar Therapeutics, will present and participate in 1x1 investor meetings at the William Blair Biotech Focus Conference 2021 taking place virtually from July 14-15, 2021.

Adamas Pharmaceuticals, Inc., a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, announced that Neil F. McFarlane, Chief Executive Officer, will participate in a fireside chat at the William Blair Biotech Focus Conference 2021 on Thursday, July 15, 2021 at 1:00 pm Eastern Time.

Beyond Air, Inc. announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, is scheduled to participate in two upcoming virtual investor conferences in July 2021.